{"id":25235,"date":"2024-04-03T14:59:40","date_gmt":"2024-04-03T14:59:40","guid":{"rendered":"https:\/\/dupmecp2.eu\/?p=25235"},"modified":"2025-07-23T10:39:41","modified_gmt":"2025-07-23T08:39:41","slug":"%ce%ba%ce%bb%ce%b9%ce%bd%ce%b9%ce%ba%ce%ad%cf%82-%ce%b4%ce%bf%ce%ba%ce%b9%ce%bc%ce%ad%cf%82-huidagene","status":"publish","type":"post","link":"https:\/\/dupmecp2.eu\/el\/%ce%ba%ce%bb%ce%b9%ce%bd%ce%b9%ce%ba%ce%ad%cf%82-%ce%b4%ce%bf%ce%ba%ce%b9%ce%bc%ce%ad%cf%82-huidagene\/","title":{"rendered":"HuidaGene: \u03c0\u03c1\u03bf\u03c2 \u03c4\u03b9\u03c2 \u03ba\u03bb\u03b9\u03bd\u03b9\u03ba\u03ad\u03c2 \u03b4\u03bf\u03ba\u03b9\u03bc\u03ad\u03c2"},"content":{"rendered":"

\u03a4\u03bf\u03bd \u03a6\u03b5\u03b2\u03c1\u03bf\u03c5\u03ac\u03c1\u03b9\u03bf \u03c4\u03bf\u03c5 2024, \u03bf David Covini, \u03c0\u03c1\u03cc\u03b5\u03b4\u03c1\u03bf\u03c2 \u03c4\u03b7\u03c2 DupMECP2, \u03b5\u03c0\u03b9\u03c3\u03ba\u03ad\u03c6\u03b8\u03b7\u03ba\u03b5 \u03c4\u03b7\u03bd \u03b5\u03c4\u03b1\u03b9\u03c1\u03b5\u03af\u03b1 \u03b2\u03b9\u03bf\u03c4\u03b5\u03c7\u03bd\u03bf\u03bb\u03bf\u03b3\u03af\u03b1\u03c2 HuidaGene Therapeutics \u03c3\u03c4\u03b7 \u03a3\u03b1\u03b3\u03ba\u03ac\u03b7. \u0397 \u03b5\u03c0\u03af\u03c3\u03ba\u03b5\u03c8\u03b7 \u03ae\u03c4\u03b1\u03bd \u03bc\u03b9\u03b1 \u03bc\u03bf\u03bd\u03b1\u03b4\u03b9\u03ba\u03ae \u03b5\u03c5\u03ba\u03b1\u03b9\u03c1\u03af\u03b1 \u03bd\u03b1 \u03b3\u03bd\u03c9\u03c1\u03af\u03c3\u03b5\u03b9 \u03bc\u03b9\u03b1 \u03b4\u03c5\u03bd\u03b1\u03bc\u03b9\u03ba\u03ae \u03bf\u03bc\u03ac\u03b4\u03b1 \u03c4\u03b7\u03c2 \u03bf\u03c0\u03bf\u03af\u03b1\u03c2 \u03c4\u03bf \u03ba\u03bb\u03b9\u03bd\u03b9\u03ba\u03cc \u03c5\u03c0\u03bf\u03c8\u03ae\u03c6\u03b9\u03bf \u03bc\u03c0\u03bf\u03c1\u03b5\u03af \u03bd\u03b1 \u03c6\u03ad\u03c1\u03b5\u03b9 \u03b5\u03c0\u03b1\u03bd\u03ac\u03c3\u03c4\u03b1\u03c3\u03b7 \u03c3\u03c4\u03bf \u03bc\u03ad\u03bb\u03bb\u03bf\u03bd \u03c4\u03b7\u03c2 \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1\u03c2 \u03c4\u03bf\u03c5 \u03c3\u03c5\u03bd\u03b4\u03c1\u03cc\u03bc\u03bf\u03c5 \u03b4\u03b9\u03c0\u03bb\u03b1\u03c3\u03b9\u03b1\u03c3\u03bc\u03bf\u03cd \u03c4\u03bf\u03c5 \u03b3\u03bf\u03bd\u03b9\u03b4\u03af\u03bf\u03c5 MECP2 (MDS). <\/p>\n\n\n\n

\u039c\u03b5 \u03b5\u03c0\u03b9\u03ba\u03b5\u03c6\u03b1\u03bb\u03ae\u03c2 \u03c4\u03bf\u03bd \u0394\u03b9\u03b5\u03c5\u03b8\u03cd\u03bd\u03bf\u03bd\u03c4\u03b1 \u03a3\u03cd\u03bc\u03b2\u03bf\u03c5\u03bb\u03bf \u03c4\u03b7\u03c2 HuidagGene \u0394\u03c1 Alvin Luk, \u03b7 \u03b5\u03c4\u03b1\u03b9\u03c1\u03b5\u03af\u03b1 \u03b2\u03c1\u03af\u03c3\u03ba\u03b5\u03c4\u03b1\u03b9 \u03c3\u03c4\u03b7\u03bd \u03c0\u03c1\u03ce\u03c4\u03b7 \u03b3\u03c1\u03b1\u03bc\u03bc\u03ae \u03c4\u03b7\u03c2 \u03b1\u03bd\u03ac\u03c0\u03c4\u03c5\u03be\u03b7\u03c2 \u03bc\u03b9\u03b1\u03c2 \u03b5\u03c0\u03b1\u03bd\u03b1\u03c3\u03c4\u03b1\u03c4\u03b9\u03ba\u03ae\u03c2 \u03c4\u03b5\u03c7\u03bd\u03bf\u03bb\u03bf\u03b3\u03af\u03b1\u03c2 \u03c0\u03bf\u03c5 \u03b8\u03b1 \u03bc\u03c0\u03bf\u03c1\u03bf\u03cd\u03c3\u03b5 \u03bd\u03b1 \u03b1\u03bb\u03bb\u03ac\u03be\u03b5\u03b9 \u03c4\u03b7 \u03b6\u03c9\u03ae \u03c4\u03c9\u03bd \u03c0\u03b1\u03b9\u03b4\u03b9\u03ce\u03bd \u03c0\u03bf\u03c5 \u03c0\u03ac\u03c3\u03c7\u03bf\u03c5\u03bd \u03b1\u03c0\u03cc MDS. \u0397 \u03b5\u03c0\u03af\u03c3\u03ba\u03b5\u03c8\u03b7 \u03ae\u03c4\u03b1\u03bd \u03bc\u03b9\u03b1 \u03b1\u03c0\u03af\u03c3\u03c4\u03b5\u03c5\u03c4\u03b7 \u03b5\u03c5\u03ba\u03b1\u03b9\u03c1\u03af\u03b1 \u03bd\u03b1 \u03b1\u03bd\u03b1\u03ba\u03b1\u03bb\u03cd\u03c8\u03bf\u03c5\u03bc\u03b5 \u03c4\u03b9\u03c2 \u03c5\u03c0\u03b5\u03c1\u03c3\u03cd\u03b3\u03c7\u03c1\u03bf\u03bd\u03b5\u03c2 \u03b5\u03b3\u03ba\u03b1\u03c4\u03b1\u03c3\u03c4\u03ac\u03c3\u03b5\u03b9\u03c2 \u03ba\u03b1\u03b9 \u03c4\u03bf \u03b4\u03b7\u03bc\u03b9\u03bf\u03c5\u03c1\u03b3\u03b9\u03ba\u03cc \u03c0\u03b5\u03c1\u03b9\u03b2\u03ac\u03bb\u03bb\u03bf\u03bd \u03c0\u03bf\u03c5 \u03c5\u03c0\u03bf\u03c3\u03c4\u03b7\u03c1\u03af\u03b6\u03b5\u03b9 \u03bc\u03b9\u03b1 \u03c4\u03ad\u03c4\u03bf\u03b9\u03b1 \u03ad\u03c1\u03b5\u03c5\u03bd\u03b1. \u0391\u03be\u03af\u03b6\u03b5\u03b9 \u03bd\u03b1 \u03c3\u03b7\u03bc\u03b5\u03b9\u03c9\u03b8\u03b5\u03af \u03cc\u03c4\u03b9 \u03bf \u03c7\u03ce\u03c1\u03bf\u03c2 \u03b3\u03c1\u03b1\u03c6\u03b5\u03af\u03c9\u03bd \u03c0\u03b5\u03c1\u03b9\u03bb\u03b1\u03bc\u03b2\u03ac\u03bd\u03b5\u03b9 \u03b1\u03ba\u03cc\u03bc\u03b7 \u03ba\u03b1\u03b9 \u03c4\u03bf\u03af\u03c7\u03bf \u03b1\u03bd\u03b1\u03c1\u03c1\u03af\u03c7\u03b7\u03c3\u03b7\u03c2, \u03ba\u03b1\u03bb\u03bb\u03b9\u03b5\u03c1\u03b3\u03ce\u03bd\u03c4\u03b1\u03c2 \u03bc\u03b9\u03b1 \u03b4\u03b7\u03bc\u03b9\u03bf\u03c5\u03c1\u03b3\u03b9\u03ba\u03ae \u03b1\u03c4\u03bc\u03cc\u03c3\u03c6\u03b1\u03b9\u03c1\u03b1 \u03b5\u03c1\u03b3\u03b1\u03c3\u03af\u03b1\u03c2. <\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

\u039f Alvin \u03ba\u03b1\u03b9 \u03b7 \u0399\u03b1\u03c4\u03c1\u03b9\u03ba\u03ae \u0394\u03b9\u03b5\u03c5\u03b8\u03cd\u03bd\u03c4\u03c1\u03b9\u03b1 \u03b3\u03b9\u03b1 \u03c4\u03bf MDS, \u0394\u03c1 Gloria Tang, \u03c0\u03b1\u03c1\u03bf\u03c5\u03c3\u03af\u03b1\u03c3\u03b1\u03bd \u03bb\u03b5\u03c0\u03c4\u03bf\u03bc\u03ad\u03c1\u03b5\u03b9\u03b5\u03c2 \u03c3\u03c7\u03b5\u03c4\u03b9\u03ba\u03ac \u03bc\u03b5 \u03c4\u03b7\u03bd \u03c4\u03b5\u03c7\u03bd\u03bf\u03bb\u03bf\u03b3\u03af\u03b1 \u03b5\u03c0\u03b5\u03be\u03b5\u03c1\u03b3\u03b1\u03c3\u03af\u03b1\u03c2 RNA CRISPR CAS13 \u03b3\u03b9\u03b1 \u03c4\u03bf \u03c3\u03cd\u03bd\u03b4\u03c1\u03bf\u03bc\u03bf \u03b3\u03bf\u03bd\u03b9\u03b4\u03b9\u03b1\u03ba\u03bf\u03cd \u03b4\u03b9\u03c0\u03bb\u03b1\u03c3\u03b9\u03b1\u03c3\u03bc\u03bf\u03cd. MECP2<\/em>\u03bc\u03b5 \u03c4\u03b7\u03bd \u03bf\u03bd\u03bf\u03bc\u03b1\u03c3\u03af\u03b1 HG204. \u0397 \u03c0\u03bf\u03bb\u03bb\u03ac \u03c5\u03c0\u03bf\u03c3\u03c7\u03cc\u03bc\u03b5\u03bd\u03b7 \u03c0\u03bf\u03b9\u03cc\u03c4\u03b7\u03c4\u03b1 \u03c4\u03c9\u03bd \u03b4\u03b5\u03b4\u03bf\u03bc\u03ad\u03bd\u03c9\u03bd \u03ba\u03b1\u03b9 \u03c4\u03b1 \u03c0\u03c1\u03bf\u03ba\u03b1\u03c4\u03b1\u03c1\u03ba\u03c4\u03b9\u03ba\u03ac \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03ad\u03c3\u03bc\u03b1\u03c4\u03b1 \u03c4\u03c9\u03bd \u03bc\u03b5\u03bb\u03b5\u03c4\u03ce\u03bd \u03c4\u03bf\u03be\u03b9\u03ba\u03cc\u03c4\u03b7\u03c4\u03b1\u03c2 \u03c3\u03b5 \u03c0\u03c1\u03c9\u03c4\u03b5\u03cd\u03bf\u03bd\u03c4\u03b1 \u03b8\u03b7\u03bb\u03b1\u03c3\u03c4\u03b9\u03ba\u03ac \u03b5\u03ba\u03c4\u03cc\u03c2 \u03c4\u03bf\u03c5 \u03b1\u03bd\u03b8\u03c1\u03ce\u03c0\u03bf\u03c5 \u03bf\u03b4\u03ae\u03b3\u03b7\u03c3\u03b1\u03bd \u03c4\u03b7\u03bd HuidaGene \u03c3\u03b5 \u03bc\u03b9\u03b1 \u03c3\u03c5\u03bd\u03b1\u03c1\u03c0\u03b1\u03c3\u03c4\u03b9\u03ba\u03ae \u03b5\u03be\u03ad\u03bb\u03b9\u03be\u03b7. \u0397 \u03ba\u03bb\u03b9\u03bd\u03b9\u03ba\u03ae \u03b4\u03bf\u03ba\u03b9\u03bc\u03ae \u03c4\u03b7\u03c2 \u03b5\u03c4\u03b1\u03b9\u03c1\u03b5\u03af\u03b1\u03c2, \u03b7 \u03bf\u03c0\u03bf\u03af\u03b1 \u03ad\u03c7\u03b5\u03b9 \u03b1\u03c1\u03c7\u03b9\u03ba\u03ac \u03c0\u03c1\u03bf\u03b3\u03c1\u03b1\u03bc\u03bc\u03b1\u03c4\u03b9\u03c3\u03c4\u03b5\u03af \u03bd\u03b1 \u03be\u03b5\u03ba\u03b9\u03bd\u03ae\u03c3\u03b5\u03b9 \u03c4\u03bf \u03b4\u03b5\u03cd\u03c4\u03b5\u03c1\u03bf \u03b5\u03be\u03ac\u03bc\u03b7\u03bd\u03bf \u03c4\u03bf\u03c5 2024, \u03ad\u03c7\u03b5\u03b9 \u03ae\u03b4\u03b7 \u03bb\u03ac\u03b2\u03b5\u03b9 \u03ad\u03b3\u03ba\u03c1\u03b9\u03c3\u03b7 \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd \u03b5\u03c0\u03b9\u03c4\u03c1\u03bf\u03c0\u03ae \u03b4\u03b5\u03bf\u03bd\u03c4\u03bf\u03bb\u03bf\u03b3\u03af\u03b1\u03c2 \u03b4\u03cd\u03bf \u03bd\u03bf\u03c3\u03bf\u03ba\u03bf\u03bc\u03b5\u03af\u03c9\u03bd, \u03bc\u03b5 \u03c3\u03c4\u03cc\u03c7\u03bf \u03bd\u03b1 \u03c3\u03c5\u03bc\u03c0\u03b5\u03c1\u03b9\u03bb\u03ac\u03b2\u03b5\u03b9 \u03b1\u03c3\u03b8\u03b5\u03bd\u03b5\u03af\u03c2 \u03bc\u03b5 MDS \u03c0\u03c1\u03b9\u03bd \u03b1\u03c0\u03cc \u03c4\u03bf \u03c4\u03ad\u03bb\u03bf\u03c2 \u03c4\u03bf\u03c5 \u03ad\u03c4\u03bf\u03c5\u03c2.<\/p>\n\n\n\n

\u0391\u03c5\u03c4\u03ac \u03b5\u03af\u03bd\u03b1\u03b9 \u03b5\u03be\u03b1\u03b9\u03c1\u03b5\u03c4\u03b9\u03ba\u03ac \u03bd\u03ad\u03b1 \u03b3\u03b9\u03b1 \u03c4\u03b7\u03bd \u03ba\u03bf\u03b9\u03bd\u03cc\u03c4\u03b7\u03c4\u03b1 \u03c4\u03bf\u03c5 MDS. \u0397 \u03b5\u03c0\u03b5\u03c1\u03c7\u03cc\u03bc\u03b5\u03bd\u03b7 \u03ba\u03bb\u03b9\u03bd\u03b9\u03ba\u03ae \u03b4\u03bf\u03ba\u03b9\u03bc\u03ae \u03c4\u03bf\u03c5 HG204 \u03b3\u03b9\u03b1 \u03c4\u03bf MDS, \u03c0\u03bf\u03c5 \u03bf\u03bd\u03bf\u03bc\u03ac\u03b6\u03b5\u03c4\u03b1\u03b9 \"HERO\", \u03b8\u03b1 \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03cd\u03c3\u03b5\u03b9 \u03b1\u03c1\u03c7\u03b9\u03ba\u03ac \u03c4\u03bf\u03c5\u03bb\u03ac\u03c7\u03b9\u03c3\u03c4\u03bf\u03bd 4 \u03b1\u03c3\u03b8\u03b5\u03bd\u03b5\u03af\u03c2 \u03bf\u03b9 \u03bf\u03c0\u03bf\u03af\u03bf\u03b9 \u03b8\u03b1 \u03c0\u03b1\u03c1\u03b1\u03ba\u03bf\u03bb\u03bf\u03c5\u03b8\u03bf\u03cd\u03bd\u03c4\u03b1\u03b9 \u03c3\u03c4\u03b5\u03bd\u03ac \u03b3\u03b9\u03b1 \u03ad\u03bd\u03b1 \u03ad\u03c4\u03bf\u03c2. \u0397 \u03c0\u03c1\u03ce\u03c4\u03b7 \u03c6\u03ac\u03c3\u03b7 \u03b1\u03c5\u03c4\u03ae\u03c2 \u03c4\u03b7\u03c2 \u03c0\u03c1\u03c9\u03c4\u03bf\u03c0\u03bf\u03c1\u03b9\u03b1\u03ba\u03ae\u03c2 \u03b4\u03bf\u03ba\u03b9\u03bc\u03ae\u03c2 \u03b8\u03b1 \u03b4\u03b9\u03b5\u03be\u03b1\u03c7\u03b8\u03b5\u03af \u03c3\u03c4\u03b7\u03bd \u039a\u03af\u03bd\u03b1. \u0397 \u03ad\u03bd\u03c4\u03b1\u03be\u03b7 \u03c0\u03b5\u03c1\u03b1\u03b9\u03c4\u03ad\u03c1\u03c9 \u03b1\u03c3\u03b8\u03b5\u03bd\u03ce\u03bd \u03c3\u03c4\u03b7\u03bd \u039a\u03af\u03bd\u03b1 \u03b8\u03b1 \u03b5\u03be\u03b1\u03c1\u03c4\u03b7\u03b8\u03b5\u03af \u03b1\u03c0\u03cc \u03c4\u03b1 \u03c0\u03c1\u03ce\u03c4\u03b1 \u03c0\u03c1\u03bf\u03ba\u03b1\u03c4\u03b1\u03c1\u03ba\u03c4\u03b9\u03ba\u03ac \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03ad\u03c3\u03bc\u03b1\u03c4\u03b1 \u03c4\u03b7\u03c2 \u03c0\u03b1\u03c1\u03b5\u03bc\u03b2\u03b1\u03c4\u03b9\u03ba\u03ae\u03c2 \u03bc\u03b5\u03bb\u03ad\u03c4\u03b7\u03c2.<\/p>\n\n\n\n

\u0397 HuidaGene \u03ad\u03c7\u03b5\u03b9 \u03ae\u03b4\u03b7 \u03c3\u03b7\u03bc\u03b5\u03b9\u03ce\u03c3\u03b5\u03b9 \u03c3\u03b7\u03bc\u03b1\u03bd\u03c4\u03b9\u03ba\u03ae \u03c0\u03c1\u03cc\u03bf\u03b4\u03bf \u03c0\u03c1\u03bf\u03c2 \u03c4\u03b7\u03bd \u03ba\u03b1\u03c4\u03b5\u03cd\u03b8\u03c5\u03bd\u03c3\u03b7 \u03c4\u03b7\u03c2 \u03ba\u03b1\u03bd\u03bf\u03bd\u03b9\u03c3\u03c4\u03b9\u03ba\u03ae\u03c2 \u03ad\u03b3\u03ba\u03c1\u03b9\u03c3\u03b7\u03c2, \u03bb\u03b1\u03bc\u03b2\u03ac\u03bd\u03bf\u03bd\u03c4\u03b1\u03c2 \u03b4\u03cd\u03bf \u03c7\u03b1\u03c1\u03b1\u03ba\u03c4\u03b7\u03c1\u03b9\u03c3\u03bc\u03bf\u03cd\u03c2 \u03b1\u03c0\u03cc \u03c4\u03bf\u03bd FDA (Rare Paediatric Disease Designation (RPDD) \u03ba\u03b1\u03b9 Orphan Drug Designation (ODD)) \u03b3\u03b9\u03b1 \u03c4\u03bf HG204. \u0388\u03c7\u03bf\u03c5\u03bd \u03b5\u03c0\u03af\u03c3\u03b7\u03c2 \u03be\u03b5\u03ba\u03b9\u03bd\u03ae\u03c3\u03b5\u03b9 \u03b5\u03c0\u03b1\u03c6\u03ad\u03c2 \u03bc\u03b5 \u03c4\u03bf\u03bd FDA \u03ba\u03b1\u03b9 \u03c4\u03bf\u03bd EMA \u03b3\u03b9\u03b1 \u03c0\u03c1\u03cc\u03c3\u03b8\u03b5\u03c4\u03b5\u03c2 \u03bc\u03b5\u03bb\u03ad\u03c4\u03b5\u03c2 \u03c3\u03c4\u03b9\u03c2 \u0397\u03a0\u0391 \u03ba\u03b1\u03b9 \u03c4\u03b7\u03bd \u0395\u03c5\u03c1\u03ce\u03c0\u03b7. <\/p>\n\n\n\n

\u0395\u03af\u03bd\u03b1\u03b9 \u03c0\u03c1\u03bf\u03bd\u03cc\u03bc\u03b9\u03bf \u03c0\u03bf\u03c5 \u03b5\u03af\u03c7\u03b1 \u03c4\u03b7\u03bd \u03b5\u03c5\u03ba\u03b1\u03b9\u03c1\u03af\u03b1 \u03bd\u03b1 \u03b3\u03bd\u03c9\u03c1\u03af\u03c3\u03c9 \u03c0\u03c1\u03bf\u03c3\u03c9\u03c0\u03b9\u03ba\u03ac \u03c4\u03bf\u03bd Alvin \u03ba\u03b1\u03b9 \u03c4\u03b7\u03bd Gloria. \u0395\u03af\u03bc\u03b1\u03c3\u03c4\u03b5 \u03b5\u03bd\u03b8\u03bf\u03c5\u03c3\u03b9\u03b1\u03c3\u03bc\u03ad\u03bd\u03bf\u03b9 \u03c0\u03bf\u03c5 \u03b5\u03af\u03bc\u03b1\u03c3\u03c4\u03b5 \u03bc\u03ad\u03c1\u03bf\u03c2 \u03b1\u03c5\u03c4\u03ae\u03c2 \u03c4\u03b7\u03c2 \u03c0\u03b5\u03c1\u03b9\u03c0\u03ad\u03c4\u03b5\u03b9\u03b1\u03c2 \u03ba\u03b1\u03b9 \u03b1\u03bd\u03c5\u03c0\u03bf\u03bc\u03bf\u03bd\u03bf\u03cd\u03bc\u03b5 \u03bd\u03b1 \u03ba\u03c1\u03b1\u03c4\u03ac\u03bc\u03b5 \u03c4\u03b7\u03bd \u03ba\u03bf\u03b9\u03bd\u03cc\u03c4\u03b7\u03c4\u03ac \u03bc\u03b1\u03c2 \u03b5\u03bd\u03ae\u03bc\u03b5\u03c1\u03b7 \u03b3\u03b9\u03b1 \u03c4\u03b7\u03bd \u03c0\u03c1\u03cc\u03bf\u03b4\u03bf \u03b1\u03c5\u03c4\u03ae\u03c2 \u03c4\u03b7\u03c2 \u03c4\u03b5\u03c7\u03bd\u03bf\u03bb\u03bf\u03b3\u03af\u03b1\u03c2 \u03c0\u03bf\u03c5 \u03bc\u03c0\u03bf\u03c1\u03b5\u03af \u03bd\u03b1 \u03b1\u03bb\u03bb\u03ac\u03be\u03b5\u03b9 \u03c4\u03b7 \u03b6\u03c9\u03ae.<\/p>\n\n\n\n

<\/p>","protected":false},"excerpt":{"rendered":"

En f\u00e9vrier 2024, David Covini, pr\u00e9sident de DupMECP2, a visit\u00e9 l’entreprise de biotechnologie HuidaGene Therapeutics \u00e0 Shanghai. Cette visite a \u00e9t\u00e9 une occasion unique de rencontrer une \u00e9quipe dynamique dont […]<\/p>","protected":false},"author":1,"featured_media":25367,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-25235","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualite"],"yoast_head":"\nHuidaGene: vers les essais cliniques - DupMECP2<\/title>\n<meta name=\"description\" content=\"En f\u00e9vrier 2024, David Covini, pr\u00e9sident de DupMECP2, a visit\u00e9 l'entreprise de biotechnologie HuidaGene Therapeutics \u00e0 Shanghai. Cette visite a \u00e9t\u00e9 une occasion unique de rencontrer une \u00e9quipe dynamique dont le candidat clinique peut r\u00e9volutionner l'avenir du traitement du syndrome de duplication du g\u00e8ne MECP2 (MDS).\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/dupmecp2.eu\/el\/\u03ba\u03bb\u03b9\u03bd\u03b9\u03ba\u03ad\u03c2-\u03b4\u03bf\u03ba\u03b9\u03bc\u03ad\u03c2-huidagene\/\" \/>\n<meta property=\"og:locale\" content=\"el_GR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HuidaGene: vers les essais cliniques - DupMECP2\" \/>\n<meta property=\"og:description\" content=\"En f\u00e9vrier 2024, David Covini, pr\u00e9sident de DupMECP2, a visit\u00e9 l'entreprise de biotechnologie HuidaGene Therapeutics \u00e0 Shanghai. Cette visite a \u00e9t\u00e9 une occasion unique de rencontrer une \u00e9quipe dynamique dont le candidat clinique peut r\u00e9volutionner l'avenir du traitement du syndrome de duplication du g\u00e8ne MECP2 (MDS).\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dupmecp2.eu\/el\/\u03ba\u03bb\u03b9\u03bd\u03b9\u03ba\u03ad\u03c2-\u03b4\u03bf\u03ba\u03b9\u03bc\u03ad\u03c2-huidagene\/\" \/>\n<meta property=\"og:site_name\" content=\"DupMECP2\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-03T14:59:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-23T08:39:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/dupmecp2.eu\/wp-content\/uploads\/2024\/04\/Huidagene_visit-02.2024-edited.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Caroline\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u03a3\u03c5\u03bd\u03c4\u03ac\u03c7\u03b8\u03b7\u03ba\u03b5 \u03b1\u03c0\u03cc\" \/>\n\t<meta name=\"twitter:data1\" content=\"Caroline\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u0395\u03ba\u03c4\u03b9\u03bc\u03ce\u03bc\u03b5\u03bd\u03bf\u03c2 \u03c7\u03c1\u03cc\u03bd\u03bf\u03c2 \u03b1\u03bd\u03ac\u03b3\u03bd\u03c9\u03c3\u03b7\u03c2\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 \u03bb\u03b5\u03c0\u03c4\u03ac\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/dupmecp2.eu\/huidagene-essais-cliniques\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/dupmecp2.eu\/huidagene-essais-cliniques\/\"},\"author\":{\"name\":\"Caroline\",\"@id\":\"https:\/\/dupmecp2.eu\/#\/schema\/person\/b41e8cbba153cd974ee340386af279ee\"},\"headline\":\"HuidaGene: vers les essais cliniques\",\"datePublished\":\"2024-04-03T14:59:40+00:00\",\"dateModified\":\"2025-07-23T08:39:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/dupmecp2.eu\/huidagene-essais-cliniques\/\"},\"wordCount\":403,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/dupmecp2.eu\/#organization\"},\"image\":{\"@id\":\"https:\/\/dupmecp2.eu\/huidagene-essais-cliniques\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/dupmecp2.eu\/wp-content\/uploads\/2024\/04\/Huidagene_visit-02.2024-edited.jpg\",\"articleSection\":[\"Actualit\u00e9\"],\"inLanguage\":\"el\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/dupmecp2.eu\/huidagene-essais-cliniques\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/dupmecp2.eu\/huidagene-essais-cliniques\/\",\"url\":\"https:\/\/dupmecp2.eu\/huidagene-essais-cliniques\/\",\"name\":\"HuidaGene: vers les essais cliniques - DupMECP2\",\"isPartOf\":{\"@id\":\"https:\/\/dupmecp2.eu\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/dupmecp2.eu\/huidagene-essais-cliniques\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/dupmecp2.eu\/huidagene-essais-cliniques\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/dupmecp2.eu\/wp-content\/uploads\/2024\/04\/Huidagene_visit-02.2024-edited.jpg\",\"datePublished\":\"2024-04-03T14:59:40+00:00\",\"dateModified\":\"2025-07-23T08:39:41+00:00\",\"description\":\"En f\u00e9vrier 2024, David Covini, pr\u00e9sident de DupMECP2, a visit\u00e9 l'entreprise de biotechnologie HuidaGene Therapeutics \u00e0 Shanghai. Cette visite a \u00e9t\u00e9 une occasion unique de rencontrer une \u00e9quipe dynamique dont le candidat clinique peut r\u00e9volutionner l'avenir du traitement du syndrome de duplication du g\u00e8ne MECP2 (MDS).\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/dupmecp2.eu\/huidagene-essais-cliniques\/#breadcrumb\"},\"inLanguage\":\"el\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/dupmecp2.eu\/huidagene-essais-cliniques\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"el\",\"@id\":\"https:\/\/dupmecp2.eu\/huidagene-essais-cliniques\/#primaryimage\",\"url\":\"https:\/\/dupmecp2.eu\/wp-content\/uploads\/2024\/04\/Huidagene_visit-02.2024-edited.jpg\",\"contentUrl\":\"https:\/\/dupmecp2.eu\/wp-content\/uploads\/2024\/04\/Huidagene_visit-02.2024-edited.jpg\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/dupmecp2.eu\/huidagene-essais-cliniques\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/dupmecp2.eu\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Actualit\u00e9\",\"item\":\"https:\/\/dupmecp2.eu\/category\/actualite\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"HuidaGene: vers les essais cliniques\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/dupmecp2.eu\/#website\",\"url\":\"https:\/\/dupmecp2.eu\/\",\"name\":\"DupMECP2\",\"description\":\"EU\",\"publisher\":{\"@id\":\"https:\/\/dupmecp2.eu\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/dupmecp2.eu\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"el\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/dupmecp2.eu\/#organization\",\"name\":\"DupMECP2\",\"url\":\"https:\/\/dupmecp2.eu\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"el\",\"@id\":\"https:\/\/dupmecp2.eu\/#\/schema\/logo\/image\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"DupMECP2\"},\"image\":{\"@id\":\"https:\/\/dupmecp2.eu\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/dupmecp2.eu\/#\/schema\/person\/b41e8cbba153cd974ee340386af279ee\",\"name\":\"Caroline\",\"sameAs\":[\"https:\/\/dupmecp2.eu\"],\"url\":\"https:\/\/dupmecp2.eu\/el\/author\/417a2385dc37aa45\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"HuidaGene: \u03c0\u03c1\u03bf\u03c2 \u03ba\u03bb\u03b9\u03bd\u03b9\u03ba\u03ad\u03c2 \u03b4\u03bf\u03ba\u03b9\u03bc\u03ad\u03c2 - DupMECP2","description":"\u03a4\u03bf\u03bd \u03a6\u03b5\u03b2\u03c1\u03bf\u03c5\u03ac\u03c1\u03b9\u03bf \u03c4\u03bf\u03c5 2024, \u03bf David Covini, \u03c0\u03c1\u03cc\u03b5\u03b4\u03c1\u03bf\u03c2 \u03c4\u03b7\u03c2 DupMECP2, \u03b5\u03c0\u03b9\u03c3\u03ba\u03ad\u03c6\u03b8\u03b7\u03ba\u03b5 \u03c4\u03b7\u03bd \u03b5\u03c4\u03b1\u03b9\u03c1\u03b5\u03af\u03b1 \u03b2\u03b9\u03bf\u03c4\u03b5\u03c7\u03bd\u03bf\u03bb\u03bf\u03b3\u03af\u03b1\u03c2 HuidaGene Therapeutics \u03c3\u03c4\u03b7 \u03a3\u03b1\u03b3\u03ba\u03ac\u03b7. \u0397 \u03b5\u03c0\u03af\u03c3\u03ba\u03b5\u03c8\u03b7 \u03ae\u03c4\u03b1\u03bd \u03bc\u03b9\u03b1 \u03bc\u03bf\u03bd\u03b1\u03b4\u03b9\u03ba\u03ae \u03b5\u03c5\u03ba\u03b1\u03b9\u03c1\u03af\u03b1 \u03bd\u03b1 \u03b3\u03bd\u03c9\u03c1\u03af\u03c3\u03b5\u03b9 \u03bc\u03b9\u03b1 \u03b4\u03c5\u03bd\u03b1\u03bc\u03b9\u03ba\u03ae \u03bf\u03bc\u03ac\u03b4\u03b1 \u03c4\u03b7\u03c2 \u03bf\u03c0\u03bf\u03af\u03b1\u03c2 \u03c4\u03bf \u03ba\u03bb\u03b9\u03bd\u03b9\u03ba\u03cc \u03c5\u03c0\u03bf\u03c8\u03ae\u03c6\u03b9\u03bf \u03bc\u03c0\u03bf\u03c1\u03b5\u03af \u03bd\u03b1 \u03c6\u03ad\u03c1\u03b5\u03b9 \u03b5\u03c0\u03b1\u03bd\u03ac\u03c3\u03c4\u03b1\u03c3\u03b7 \u03c3\u03c4\u03bf \u03bc\u03ad\u03bb\u03bb\u03bf\u03bd \u03c4\u03b7\u03c2 \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1\u03c2 \u03c4\u03bf\u03c5 \u03c3\u03c5\u03bd\u03b4\u03c1\u03cc\u03bc\u03bf\u03c5 \u03b4\u03b9\u03c0\u03bb\u03b1\u03c3\u03b9\u03b1\u03c3\u03bc\u03bf\u03cd \u03c4\u03bf\u03c5 \u03b3\u03bf\u03bd\u03b9\u03b4\u03af\u03bf\u03c5 MECP2 (MDS).\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/dupmecp2.eu\/el\/\u03ba\u03bb\u03b9\u03bd\u03b9\u03ba\u03ad\u03c2-\u03b4\u03bf\u03ba\u03b9\u03bc\u03ad\u03c2-huidagene\/","og_locale":"el_GR","og_type":"article","og_title":"HuidaGene: vers les essais cliniques - DupMECP2","og_description":"En f\u00e9vrier 2024, David Covini, pr\u00e9sident de DupMECP2, a visit\u00e9 l'entreprise de biotechnologie HuidaGene Therapeutics \u00e0 Shanghai. Cette visite a \u00e9t\u00e9 une occasion unique de rencontrer une \u00e9quipe dynamique dont le candidat clinique peut r\u00e9volutionner l'avenir du traitement du syndrome de duplication du g\u00e8ne MECP2 (MDS).\u00a0","og_url":"https:\/\/dupmecp2.eu\/el\/\u03ba\u03bb\u03b9\u03bd\u03b9\u03ba\u03ad\u03c2-\u03b4\u03bf\u03ba\u03b9\u03bc\u03ad\u03c2-huidagene\/","og_site_name":"DupMECP2","article_published_time":"2024-04-03T14:59:40+00:00","article_modified_time":"2025-07-23T08:39:41+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/dupmecp2.eu\/wp-content\/uploads\/2024\/04\/Huidagene_visit-02.2024-edited.jpg","type":"image\/jpeg"}],"author":"Caroline","twitter_card":"summary_large_image","twitter_misc":{"\u03a3\u03c5\u03bd\u03c4\u03ac\u03c7\u03b8\u03b7\u03ba\u03b5 \u03b1\u03c0\u03cc":"Caroline","\u0395\u03ba\u03c4\u03b9\u03bc\u03ce\u03bc\u03b5\u03bd\u03bf\u03c2 \u03c7\u03c1\u03cc\u03bd\u03bf\u03c2 \u03b1\u03bd\u03ac\u03b3\u03bd\u03c9\u03c3\u03b7\u03c2":"3 \u03bb\u03b5\u03c0\u03c4\u03ac"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/dupmecp2.eu\/huidagene-essais-cliniques\/#article","isPartOf":{"@id":"https:\/\/dupmecp2.eu\/huidagene-essais-cliniques\/"},"author":{"name":"Caroline","@id":"https:\/\/dupmecp2.eu\/#\/schema\/person\/b41e8cbba153cd974ee340386af279ee"},"headline":"HuidaGene: vers les essais cliniques","datePublished":"2024-04-03T14:59:40+00:00","dateModified":"2025-07-23T08:39:41+00:00","mainEntityOfPage":{"@id":"https:\/\/dupmecp2.eu\/huidagene-essais-cliniques\/"},"wordCount":403,"commentCount":0,"publisher":{"@id":"https:\/\/dupmecp2.eu\/#organization"},"image":{"@id":"https:\/\/dupmecp2.eu\/huidagene-essais-cliniques\/#primaryimage"},"thumbnailUrl":"https:\/\/dupmecp2.eu\/wp-content\/uploads\/2024\/04\/Huidagene_visit-02.2024-edited.jpg","articleSection":["Actualit\u00e9"],"inLanguage":"el","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/dupmecp2.eu\/huidagene-essais-cliniques\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/dupmecp2.eu\/huidagene-essais-cliniques\/","url":"https:\/\/dupmecp2.eu\/huidagene-essais-cliniques\/","name":"HuidaGene: \u03c0\u03c1\u03bf\u03c2 \u03ba\u03bb\u03b9\u03bd\u03b9\u03ba\u03ad\u03c2 \u03b4\u03bf\u03ba\u03b9\u03bc\u03ad\u03c2 - DupMECP2","isPartOf":{"@id":"https:\/\/dupmecp2.eu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/dupmecp2.eu\/huidagene-essais-cliniques\/#primaryimage"},"image":{"@id":"https:\/\/dupmecp2.eu\/huidagene-essais-cliniques\/#primaryimage"},"thumbnailUrl":"https:\/\/dupmecp2.eu\/wp-content\/uploads\/2024\/04\/Huidagene_visit-02.2024-edited.jpg","datePublished":"2024-04-03T14:59:40+00:00","dateModified":"2025-07-23T08:39:41+00:00","description":"\u03a4\u03bf\u03bd \u03a6\u03b5\u03b2\u03c1\u03bf\u03c5\u03ac\u03c1\u03b9\u03bf \u03c4\u03bf\u03c5 2024, \u03bf David Covini, \u03c0\u03c1\u03cc\u03b5\u03b4\u03c1\u03bf\u03c2 \u03c4\u03b7\u03c2 DupMECP2, \u03b5\u03c0\u03b9\u03c3\u03ba\u03ad\u03c6\u03b8\u03b7\u03ba\u03b5 \u03c4\u03b7\u03bd \u03b5\u03c4\u03b1\u03b9\u03c1\u03b5\u03af\u03b1 \u03b2\u03b9\u03bf\u03c4\u03b5\u03c7\u03bd\u03bf\u03bb\u03bf\u03b3\u03af\u03b1\u03c2 HuidaGene Therapeutics \u03c3\u03c4\u03b7 \u03a3\u03b1\u03b3\u03ba\u03ac\u03b7. \u0397 \u03b5\u03c0\u03af\u03c3\u03ba\u03b5\u03c8\u03b7 \u03ae\u03c4\u03b1\u03bd \u03bc\u03b9\u03b1 \u03bc\u03bf\u03bd\u03b1\u03b4\u03b9\u03ba\u03ae \u03b5\u03c5\u03ba\u03b1\u03b9\u03c1\u03af\u03b1 \u03bd\u03b1 \u03b3\u03bd\u03c9\u03c1\u03af\u03c3\u03b5\u03b9 \u03bc\u03b9\u03b1 \u03b4\u03c5\u03bd\u03b1\u03bc\u03b9\u03ba\u03ae \u03bf\u03bc\u03ac\u03b4\u03b1 \u03c4\u03b7\u03c2 \u03bf\u03c0\u03bf\u03af\u03b1\u03c2 \u03c4\u03bf \u03ba\u03bb\u03b9\u03bd\u03b9\u03ba\u03cc \u03c5\u03c0\u03bf\u03c8\u03ae\u03c6\u03b9\u03bf \u03bc\u03c0\u03bf\u03c1\u03b5\u03af \u03bd\u03b1 \u03c6\u03ad\u03c1\u03b5\u03b9 \u03b5\u03c0\u03b1\u03bd\u03ac\u03c3\u03c4\u03b1\u03c3\u03b7 \u03c3\u03c4\u03bf \u03bc\u03ad\u03bb\u03bb\u03bf\u03bd \u03c4\u03b7\u03c2 \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1\u03c2 \u03c4\u03bf\u03c5 \u03c3\u03c5\u03bd\u03b4\u03c1\u03cc\u03bc\u03bf\u03c5 \u03b4\u03b9\u03c0\u03bb\u03b1\u03c3\u03b9\u03b1\u03c3\u03bc\u03bf\u03cd \u03c4\u03bf\u03c5 \u03b3\u03bf\u03bd\u03b9\u03b4\u03af\u03bf\u03c5 MECP2 (MDS).\u00a0","breadcrumb":{"@id":"https:\/\/dupmecp2.eu\/huidagene-essais-cliniques\/#breadcrumb"},"inLanguage":"el","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dupmecp2.eu\/huidagene-essais-cliniques\/"]}]},{"@type":"ImageObject","inLanguage":"el","@id":"https:\/\/dupmecp2.eu\/huidagene-essais-cliniques\/#primaryimage","url":"https:\/\/dupmecp2.eu\/wp-content\/uploads\/2024\/04\/Huidagene_visit-02.2024-edited.jpg","contentUrl":"https:\/\/dupmecp2.eu\/wp-content\/uploads\/2024\/04\/Huidagene_visit-02.2024-edited.jpg","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/dupmecp2.eu\/huidagene-essais-cliniques\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/dupmecp2.eu\/"},{"@type":"ListItem","position":2,"name":"Actualit\u00e9","item":"https:\/\/dupmecp2.eu\/category\/actualite\/"},{"@type":"ListItem","position":3,"name":"HuidaGene: vers les essais cliniques"}]},{"@type":"WebSite","@id":"https:\/\/dupmecp2.eu\/#website","url":"https:\/\/dupmecp2.eu\/","name":"DupMECP2","description":"\u0395\u0395","publisher":{"@id":"https:\/\/dupmecp2.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dupmecp2.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"el"},{"@type":"Organization","@id":"https:\/\/dupmecp2.eu\/#organization","name":"DupMECP2","url":"https:\/\/dupmecp2.eu\/","logo":{"@type":"ImageObject","inLanguage":"el","@id":"https:\/\/dupmecp2.eu\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"DupMECP2"},"image":{"@id":"https:\/\/dupmecp2.eu\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/dupmecp2.eu\/#\/schema\/person\/b41e8cbba153cd974ee340386af279ee","name":"\u039a\u03b1\u03c1\u03bf\u03bb\u03af\u03bd\u03b1","sameAs":["https:\/\/dupmecp2.eu"],"url":"https:\/\/dupmecp2.eu\/el\/author\/417a2385dc37aa45\/"}]}},"_links":{"self":[{"href":"https:\/\/dupmecp2.eu\/el\/wp-json\/wp\/v2\/posts\/25235","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dupmecp2.eu\/el\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dupmecp2.eu\/el\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dupmecp2.eu\/el\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dupmecp2.eu\/el\/wp-json\/wp\/v2\/comments?post=25235"}],"version-history":[{"count":1,"href":"https:\/\/dupmecp2.eu\/el\/wp-json\/wp\/v2\/posts\/25235\/revisions"}],"predecessor-version":[{"id":33411,"href":"https:\/\/dupmecp2.eu\/el\/wp-json\/wp\/v2\/posts\/25235\/revisions\/33411"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dupmecp2.eu\/el\/wp-json\/wp\/v2\/media\/25367"}],"wp:attachment":[{"href":"https:\/\/dupmecp2.eu\/el\/wp-json\/wp\/v2\/media?parent=25235"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dupmecp2.eu\/el\/wp-json\/wp\/v2\/categories?post=25235"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dupmecp2.eu\/el\/wp-json\/wp\/v2\/tags?post=25235"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}